Elevation Oncology, Inc.
ELEV
$0.381
-$0.0039-1.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.73% | -32.12% | -21.11% | -3.47% | 37.24% |
| Total Depreciation and Amortization | -50.00% | -50.00% | -44.44% | -60.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.61% | 6,557.14% | 0.12% | -9.73% | 17.01% |
| Change in Net Operating Assets | 206.12% | 84.22% | 203.52% | 131.38% | 51.91% |
| Cash from Operations | -32.75% | 16.25% | 37.25% | 40.59% | 43.11% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.77% | 74.82% | 92.46% | -328.24% | -22.18% |
| Cash from Investing | 14.77% | 74.82% | 92.46% | -328.24% | -22.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -60.00% | -69.17% | 13,244.74% |
| Repurchase of Common Stock | 34.62% | -100.00% | 33.33% | -128.57% | -116.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.06% | -100.00% | -62.96% | -69.24% | 13,904.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.34% | 122.44% | 78.14% | -161.84% | 314.37% |